Skip to main content

Ariosa Signs UK Distribution Deal for Harmony Prenatal Test; Plans to Expand Indications

NEW YORK (GenomeWeb News) — Ariosa Diagnostics said today that it is partnering with the Doctors Laboratory to distribute its Harmony Prenatal Test in the UK.

Under the terms of the agreement, the Doctors Laboratory, a clinical pathology testing services organization, will offer the Harmony test to doctors and their pregnant patients. The Doctors Laboratory is based in London with smaller laboratories positioned throughout the UK.

Separately, Ariosa said that it plans to expand the indications for the Harmony test, which analyzes cell-free DNA circulating in maternal blood in order to detect fetal trisomies.

The company said that it will expand the test's indications to include all in vitro fertilization singleton pregnancies, including unrelated egg donor and surrogate pregnancies, but did not provide a timeline for the launch of the expanded test.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.